Pulmonx Corporation LUNG Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.59M-8.9% | $22.6M+5.1% | $21.5M-9.9% | $23.86M+5.9% | $22.54M-5.2% | ||
| $4.54M-10.2% | $5.06M-7.2% | $5.45M-18.1% | $6.66M+7.4% | $6.2M+0.3% | ||
| $16.04M-8.5% | $17.54M+9.3% | $16.05M-6.7% | $17.2M+5.3% | $16.34M-7.1% | ||
| 77.9%+0.3pp | 77.6%+3.0pp | 74.7%+2.5pp | 72.1%-0.4pp | 72.5%-1.5pp | ||
| $4.9M+6.9% | $4.58M-5.4% | $4.85M-8.7% | $5.31M+11.6% | $4.76M+18.9% | ||
| $24.1M+5.4% | $22.86M-10.7% | $25.6M-4.1% | $26.7M+2.1% | $26.15M-3.2% | ||
| $29M+5.7% | $27.44M-9.9% | $30.45M-4.9% | $32.01M+3.6% | $30.91M-0.3% | ||
| $29M+5.7% | $27.44M-9.9% | $30.45M-4.9% | $32.01M+3.6% | $30.91M-0.3% | ||
| -$12.96M-30.8% | -$9.9M+31.2% | -$14.39M+2.8% | -$14.8M-1.7% | -$14.56M-8.5% | ||
| -62.9%-19.1pp | -43.8%+23.1pp | -66.9%-4.9pp | -62%+2.6pp | -64.6%-8.2pp | ||
| $976K+26.8% | $770K-4.3% | $805K+0.8% | $799K+2.3% | $781K-7.2% | ||
| $350K-22.7% | $453K-25.9% | $611K-15.5% | $723K-16.3% | $864K-17.3% | ||
| $77K— | $0-100% | $758K+753% | -$116K-169% | $167K+117% | ||
| -$13.51M-31.9% | -$10.24M+26.0% | -$13.83M+7.8% | -$15M-4.8% | -$14.31M-9.0% | ||
| $149K-19.9% | $186K+45.3% | $128K-27.7% | $177K+31.1% | $135K+255% | ||
| -$13.65M-31.0% | -$10.43M+25.3% | -$13.96M+8.0% | -$15.17M-5.0% | -$14.45M-9.7% | ||
| -66.3%-20.2pp | -46.1%+18.8pp | -64.9%-1.3pp | -63.6%+0.5pp | -64.1%-8.7pp | ||
| -$0.33-32.0% | -$0.25+26.5% | -$0.34+10.5% | -$0.38-5.6% | -$0.36-9.1% | ||
| -$0.33-32.0% | -$0.25+26.5% | -$0.34+10.5% | -$0.38-5.6% | -$0.36-9.1% | ||
| 41.9M+3.0% | 40.7M-0.6% | 40.9M+1.3% | 40.4M+1.2% | 40M+2.2% | ||
| 41.9M+3.0% | 40.7M-0.6% | 40.9M+1.3% | 40.4M+1.2% | 40M+2.2% | ||
| -$13.85M-34.4% | -$10.3M+28.2% | -$14.36M+2.6% | -$14.74M-2.6% | -$14.36M-5.6% | ||
| $77K— | $0-100% | $758K+753% | -$116K-169% | $167K+117% | ||
| $20.59M-8.9% | $22.6M+5.1% | $21.5M-9.9% | $23.86M+5.9% | $22.54M-5.2% | ||
| -$12.96M-30.8% | -$9.9M+31.2% | -$14.39M+2.8% | -$14.8M-1.7% | -$14.56M-8.5% | ||
| -$12.74M-31.7% | -$9.67M+31.6% | -$14.15M+2.5% | -$14.51M-1.5% | -$14.29M-8.9% | ||
| -$12.74M-31.7% | -$9.67M+31.6% | -$14.15M+2.5% | -$14.51M-1.5% | -$14.29M-8.9% | ||
| -61.9%-19.1pp | -42.8%+23.0pp | -65.8%-5.0pp | -60.8%+2.6pp | -63.4%-8.2pp | ||
| -$12.96M-30.8% | -$9.9M+31.2% | -$14.39M+2.8% | -$14.8M-1.7% | -$14.56M-8.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pulmonx Corporation's revenue?
- Pulmonx Corporation (LUNG) generated $88.5M in revenue over the trailing twelve months, up 1.2% year over year.
- Is Pulmonx Corporation profitable?
- Pulmonx Corporation is not currently profitable: it reported a net loss of $53.2M over the trailing twelve months, a -60.1% net margin.
- What are Pulmonx Corporation's profit margins?
- Gross margin is 75.5% and operating margin is -58.8%, with a -60.1% net margin.
- What is Pulmonx Corporation's earnings per share?
- Pulmonx Corporation's diluted EPS over the trailing twelve months is $-1.30.
- Where does Pulmonx Corporation's income statement data come from?
- Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
